Should Age 65 be a cutoff for Primary Progressive Multiple Sclerosis therapy? Real World Data is Critical

Share this article

Anyone you share the following link with will be able to read this content:

Get shareable link

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Comments (0)

No login
gif